跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Seficare ODT solifenacin succinate 5 mg orodispersible tablets blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
Seficare ODT solifenacin succinate 5 mg orodispersible tablets blister pack
Approved
STANDARD
Seficare ODT solifenacin succinate 5 mg orodispersible tablets blister pack
Accord Healthcare Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
d0f718b8955e5ee5
Company
Accord Healthcare Pty Ltd
Type
Standard
Approval Details
Approval Id
d0f718b8955e5ee5
Product Name
Seficare ODT solifenacin succinate 5 mg orodispersible tablets blister pack
Artg Id
316986
Artg Name
Seficare ODT solifenacin succinate 5 mg orodispersible tablets blister pack
Sponsor
Accord Healthcare Pty Ltd
Company Detail Path
/organization/accord-healthcare-pty-ltd
Artg Date
2020-09-17
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
d0f718b8955e5ee5
Type
Standard
Back to TGA Approvals
